technologies infograph

Computer Aided Antibody Design(CAAD)

Traditional Technologies Hybridoma

Traditional Technologies Phage Display

Process

Focusing on growing shareholder value

shape

shape

Imbalanced Bispecific Antibody Technology Platform "KIH” + commonlight chain format: Similar to Emicizumab "Imbalanced” Dual antigen binding: Best fit for each unique MOA CAAD: Designed common LC + designed ideal biochemical and biophysical features

Biospecific involves a CD3 binder

biospecific

Biospecific against a CSA (cancer specific antigen) & CAA (cancer associated antigen)

csa

Biospecific against one target for CNS and another target on BBB

bba

Development of a novel "imbalanced" CSA bispecific antibody by computational design

Case Study

shape

Biospecific involves a CD3 binder

unique features

Development of Multi-Specific Antibodies by Computational Design

Case Study

shape

Start from unknown target antigen

antigen

Start from known target antigen

antigen

Unique feature of second strategy: Screening internalization caused by primary Ab.

screening internalization

Ab Studio's Internalizing Antibody Case Study: Antibody Against Cancer Antigen-X

Case Study

shape

shape